Daré Bioscience (DARE) Competitors

Anixa Biosciences (NASDAQ:ANIX) and Daré Bioscience (NASDAQ:DARE) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, community ranking, risk, profitability, institutional ownership, media sentiment, dividends, earnings and analyst recommendations.

Which has more volatility & risk, ANIX or DARE?

Anixa Biosciences has a beta of 0.34, meaning that its stock price is 66% less volatile than the S&P 500. Comparatively, Daré Bioscience has a beta of 1.2, meaning that its stock price is 20% more volatile than the S&P 500.

Does the MarketBeat Community prefer ANIX or DARE?

Daré Bioscience received 324 more outperform votes than Anixa Biosciences when rated by MarketBeat users. However, 75.56% of users gave Anixa Biosciences an outperform vote while only 73.36% of users gave Daré Bioscience an outperform vote.

Company	Underperform	Outperform
Anixa Biosciences	Outperform Votes 34 75.56%	Underperform Votes 11 24.44%
Daré Bioscience	Outperform Votes 358 73.36%	Underperform Votes 130 26.64%

Do analysts prefer ANIX or DARE?

Anixa Biosciences currently has a consensus target price of $9.00, indicating a potential upside of 152.81%. Daré Bioscience has a consensus target price of $12.00, indicating a potential upside of 280.95%. Given Daré Bioscience's higher probable upside, analysts clearly believe Daré Bioscience is more favorable than Anixa Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Anixa Biosciences	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	3.25
Daré Bioscience	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50

Which has higher valuation and earnings, ANIX or DARE?

Anixa Biosciences has higher revenue and earnings than Daré Bioscience. Daré Bioscience is trading at a lower price-to-earnings ratio than Anixa Biosciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Anixa Biosciences	$210K	546.05	-$12.55M	-$0.38	-9.37
Daré Bioscience	$25.91K	1,075.98	-$30.16M	-$0.17	-18.53

Is ANIX or DARE more profitable?

Anixa Biosciences has a net margin of 0.00% compared to Daré Bioscience's net margin of -191.65%. Daré Bioscience's return on equity of 0.00% beat Anixa Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Anixa Biosciences	N/A	-58.55%	-53.29%
Daré Bioscience	-191.65%	N/A	-18.98%

Do insiders & institutionals believe in ANIX or DARE?

29.1% of Anixa Biosciences shares are held by institutional investors. Comparatively, 6.7% of Daré Bioscience shares are held by institutional investors. 25.3% of Anixa Biosciences shares are held by company insiders. Comparatively, 4.0% of Daré Bioscience shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Does the media refer more to ANIX or DARE?

In the previous week, Anixa Biosciences had 4 more articles in the media than Daré Bioscience. MarketBeat recorded 13 mentions for Anixa Biosciences and 9 mentions for Daré Bioscience. Anixa Biosciences' average media sentiment score of 0.67 beat Daré Bioscience's score of 0.17 indicating that Anixa Biosciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Anixa Biosciences	2 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Daré Bioscience	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Anixa Biosciences beats Daré Bioscience on 11 of the 19 factors compared between the two stocks.